CorMedix Inc (NASDAQ:CRMD) price closed lower on Monday, April 15, dropping -7.88% below its previous close.
A look at the daily price movement shows that the last close reads $5.84. The company’s 5Y monthly beta was ticking 1.89. Taking into account the 52-week price action we note that the stock hit a 52-week high of $7.00 and 52-week low of $2.57. The stock added 28.71% on its value in the past month.
CorMedix Inc, which has a market valuation of $295.79 million, is expected to release its quarterly earnings report May 13, 2024 – May 17, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give CRMD a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that CRMD’s price is at present 21.97% off the SMA20 and 42.16% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 63.96, with weekly volatility standing at 16.53%. The indicator jumps to 7.79% when calculated based on the past 30 days. CorMedix Inc (NASDAQ:CRMD)’s beta value is holding at 1.80, while the average true range (ATR) indicator is currently reading 0.43.
An analysis of the CorMedix Inc (NASDAQ:CRMD) stock in terms of its daily trading volume indicates that the 3-month average is 531.38K.
Current records show that the company has 54.94M in outstanding shares. The insiders’ percentage holdings are 2.03% of outstanding shares while the percentage share held by institutions stands at 33.77%. But the 43.09% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
